Management of Chronic Wounds
The best approach for managing chronic wounds involves five basic principles: offloading of plantar ulcerations, debridement of necrotic tissue, revascularization when necessary, management of infection, and use of physiologic topical dressings. 1
Initial Management Strategy
- Offloading of plantar ulcerations is essential to reduce pressure on the wound site and promote healing 1
- Debridement of necrotic, nonviable tissue converts a biologically chronic wound to an acute wound, accelerating the healing process 1
- Revascularization of ischemic wounds should be performed when necessary to improve blood supply to the affected area 1
- Management of infection (both soft tissue and bone) through appropriate antimicrobial therapy is crucial for wound healing 1
- Use of physiologic, topical dressings to maintain a moist wound environment while controlling exudate 1
Advanced Wound Therapy
When to consider advanced wound therapy:
- If a wound fails to show at least 50% reduction after 4 weeks of appropriate standard wound management 1
- Treatment of chronic wounds is best managed in a multidisciplinary/interprofessional setting 1
Advanced wound therapy options include:
Negative-pressure wound therapy
Oxygen therapies
Growth factors
Biophysical modalities
Acellular matrix tissues and bioengineered cellular therapies
Special Considerations
For diabetic foot ulcers (DFUs):
For venous leg ulcers (VLUs):
Common Pitfalls to Avoid
- Failing to reassess underlying pathology when wounds don't improve after 4 weeks 3
- Using advanced therapies without first addressing the five basic principles of wound care 1
- Overlooking the importance of treating the underlying cause of the chronic wound 4
- Using topical antimicrobial dressings without clear indication, as they have shown no benefit in venous ulcers 1
- Neglecting to evaluate for osteomyelitis in non-healing ulcers 1
Evidence Quality Considerations
Evidence to support advanced wound therapy is challenging to produce and assess due to:
Products or agents with robust RCTs or systematic reviews should generally be preferred over those without level 1 evidence 1